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During characterization of some peptides (linear precursors of the cyclic peptides showing
potential to be anticancer drugs) in an ion trap, it was noted that many internal amino acid
residues could be lost from singly charged b ions. The phenomenon was not obvious at the first
stage of collisionally activated decomposition (CAD), but was apparent at multiple stages of
CAD. The unique fragmentation consisting of multiple steps is induced by a cyclization
reaction of b ions, the mechanism of which has been probed by experiments of N-acetylation,
MSn, rearranged-ion design, and activation-time adjustment. The fragmentation of synthetic
cyclic peptides demonstrates that a cyclic peptide intermediate (CPI) formed by b ion
cyclization exhibits the same fragmentation pattern as a protonated cyclic peptide. Although
no rules for the cyclization reaction were discerned in the experiments of peptide modification,
the fragmentations of a number of b ions indicate that the “Pro and Asn/Gln effects” can
influence ring openings of CPIs. In addition, large-scale losses of internal residues from
different positions of a-type ions have been observed when pure helium was used as collision
gas. The fragmentation is initiated by a cyclization reaction forming an a-type ion CPI. This CPI
with a fixed-charge structure cannot be influenced by the “Pro effect”, causing a selective ring
opening at the amide bond Pro-Xxx rather than Xxx-Pro. With the knowledge of the unique
fragmentations leading to internal residue losses, the misidentification of fragments and
sequences of peptides may be avoided. (J Am Soc Mass Spectrom 2007, 18, 663–678) © 2007
American Society for Mass SpectrometryTandem mass spectrometry (MS/MS) plays a keyrole in the characterization of the primary struc-tures of proteins and peptides. In the last two
decades, innovations in MS instrumentation and tech-
niques fundamentally drove the development of pro-
teomics [1, 2]. So far, two approaches have been devel-
oped for protein identification [3]: top-down [4] and
bottom-up [5, 6] sequencings. For the top-down se-
quencing, the protein sample without enzymatic diges-
tion is transferred into the gas phase intact, which has
the potential for 100% sequence coverage of the protein
and improved detection of post-translational modifica-
tions [4]. The bottom-up sequencing requires MS/MS
analysis of the proteolytic fragments and database
searching using algorithms such as Mascot and Sequest
[5, 6]. In addition, structural elucidations of natural or
synthetic peptides, including linear peptides [7, 8],
cyclic peptides [9, 10], and peptide analogues [11] also
rely on MS/MS analysis. Undoubtedly, all of the appli-
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doi:10.1016/j.jasms.2006.12.002cations described above are based on understanding the
dissociation mechanisms of peptides, which have been
well summarized in recent reviews [12–16]. However,
conventional knowledge of fragmentation pathways
and rules cannot reasonably explain many anomalous
fragmentations. For example, some groups have re-
ported that certain peptides show enhanced cleavage at
special amino acid residues to produce incomplete
sequence information [15]. Hence, the study on fragment-
ion intensity relationship was of further concern and
specially reviewed by Paizs and Suhai [16]. Also, an-
other class of anomalous fragmentations introduced in
this paper should receive attention.
For peptide sequencing, the ideal fragmentation pat-
tern of peptides is that the amino acid residues are
sequentially lost from the C/N-terminus. However, if
the residues are lost from the interior of the peptide
chain, the peptide sequence will be easily misidentified.
Referring to related literatures [17–23], we summarize
this class of anomalous fragmentations accompanied by
losses of internal amino acid residues into three steps
(Scheme 1). (1) A cyclic peptide intermediate (CPI) is
formed through a nucleophilic attack by the electron-
rich group on the electron-poor group of the peptide
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664 JIA ET AL. J Am Soc Mass Spectrom 2007, 18, 663–678chain. (2) The CPI ring reopens at other sites, producing
linear fragment ions where internal residues are relo-
cated at the C/N-termini. (3) The linear fragment ions
further dissociate via conventional fragmentation path-
ways, forming daughter ions with neutral losses of
internal residues from the parent ion. Obviously, the
cyclization reaction is critical for inducing this class of
fragmentations. The related literature is briefly de-
scribed as follows.
Tang et al. [17, 18] have reported a head to side-chain
cyclization of b2 ions leading to internal residue losses,
which proceeds via electrophilic attack by the protonated
-amino group of Lys (or Orn) in [M  H]2 on the
backbone amide carbonyl groups at/near the C-terminus.
The analogous behavior of Lys was also observed by
Fuchs and Budzikiewicz [21] in MS/MS analysis of
pyoverdins. Subsequently, Yagüe et al. [22] described a
head-to-tail cyclization of b2 ions, arising from a nucleo-
philic attack by the N-terminal nitrogen over the carbonyl
carbon of one peptide bond. The investigations described
above focused on doubly charged ions. For singly charged
ions, Vachet et al. [19] suggested that the a-type ion can
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Scheme 1undergo a head-to-tail cyclization reaction accompaniedby an NH3 loss from N-terminus, which was also pro-
posed by Harrison and Young [24]. A similar dissociation
pattern was observed by Craig and Taylor [20] during
characterization of plicatamide 1. Recently, in the negative
ion spectra of citropin 1.1 and analogues, Brinkworth et al.
[23] found that the loss of an internal Val residue was
induced by a head-to-tail cyclization between the CONH
group of the C-terminus and the carbonyl group of the
Ser-Val amide bond. Coincidentally, when our manu-
script was being prepared, Harrison et al. [25] published a
communication, which showed that b ions could be cy-
clized by attack of the N-terminal amino group on the
carbonyl carbon of C-terminal oxazolone ring. These find-
ings described above suggest that the cyclization reactions
leading to internal residue losses frequently occur during
peptide fragmentations and need to be further studied.
In our previous work [26], using multistep MS/MS in
an ion trap we sequenced some cyclic peptides and
observed some anomalous ions with internal residue
losses as reported by Ngoka and Gross [10] as well as
Stefanowicz [27]. In the present work, we divert our
attention to investigating the unique fragmentation of b
ions from linear peptides. At the first stage of CAD, this
unique fragmentation of singly charged b ions is difficult
to be observed as reported by Yagüe et al. [22]. However,
under multistage CAD almost all of the investigated b
ions (containing three to seven residues) notably display
the unique fragmentation pattern, which is quite inten-
sive. This paper focuses on studying the cyclization mech-
anisms of b ions, which are probed by the experiments
including N-acetylation, MSn, rearranged-ion design,
activation-time adjustment, synthetic cyclic peptide frag-
mentation and peptide modification. Particular attention
is paid on discussing the relationship between the frag-
mentation patterns of the CPI produced by b ion cycliza-
tion and the protonated cyclic peptide produced by elec-
trospray ionization (ESI). We attempt to introduce the
fragmentationmechanism of cyclic peptides into CPIs and
to find some valuable predictive rules, e.g., the “Pro and
Asn/Gln effects” [26, 28 –30]. Vachet and Glish [19] have
reported that residues can be lost from the second posi-
tions of C-termini of a-type ions when amixture of helium
and 5% xenon was used as collision gas in an ion trap.
Following their research, we observed this phenomenon
using 100% helium as collision gas. In addition, it was
found that not only the internal residues at the second
position of C-terminus [19] but also those at other posi-
tions could be eliminated. Moreover, another interesting
phenomenon is that the amide bond Pro-Xxx rather than
Xxx-Pro in CPIs formed by a-type ion cyclization exhibits
enhanced cleavage, and a tentative explanation has been
proposed in this research.
Experimental
Materials and Reagents
Wang-resin, Fmoc-amino acids, and coupling reagents
for peptide synthesis were purchased from GL Biochem
665J Am Soc Mass Spectrom 2007, 18, 663–678 CYCLIZATION REACTION OF FRAGMENT IONS(Shanghai, China). All solvents for peptide synthesis
were commercial analytical grade and were redistilled
before use. HPLC-grade formic acid and acetonitrile
were supplied by Merck (Darmstadt, Germany).
Peptide Synthesis and Chemical Modifications
The linear peptides were prepared manually using
Wang-resin as solid support following the Fmoc meth-
odology. The obtained linear peptides were cyclized in
solution to yield the cyclic peptides. The details were
described in our previous reports [26, 31]. Acetylation
of the free amine moiety at the N-terminus of peptide
was achieved by adding 50% (vol/vol) acetic anhydride
in pyridine to the peptide-resin following a final depro-
tection step (before the final cleavage from resin).
Mass Spectrometry Conditions
Experiments were performed with a Finnigan LCQ
ion-trap mass spectrometer (San Jose, CA) equipped
with an ESI source. The spray needle was set at a
potential of 5.0 kV and a nitrogen sheath gas flow of
20 (arbitrary units) was used to stabilize the spray.
The capillary temperature was maintained at 200 °C.
The tube-lens offset was 20 V and the electron mul-
tiplier voltage was 800 V. Helium gas was intro-
duced into the ion trap to improve the trapping
efficiency of the analyte ions introduced into the ion
trap. The background helium gas also served as the
collision gas during the CAD event. A 50 pmol/l
solution of peptide in 50:50 (vol/vol) acetonitrile/
H2O containing 1% formic acid was infused into the
mass spectrometer at a flow-rate of 2 l/min by
syringe pump. Isolation widths of 1.0 m/z and activa-
tion times of 30 ms were used at each stage of CAD;
400 scans were averaged. Spectra were acquired in
the centroid mode.
Nomenclature for Labeling the Fragment Ions
The nomenclature for labeling the conventional frag-
ment ions of peptides was developed by Roepstorff
and Fohlmann [32] and Biemann [33]. An extension
[18, 22] of this nomenclature is used to label the
anomalous ions with internal residue losses. The
general formula is “xn–AA. . .,” where “xn” is the
designation for the ion such as “an” and “bn” and
“AA. . .”, are the one letter codes of lost amino acid
sequence. In addition, “*” and “0” superscripts, re-
spectively, denote neutral loss of one ammonia mo-
lecular and one water molecule; “E” superscript
denotes N-acetylation fragment ion. Because all ions
in this study are singly charged, for simplicity no
special symbol is used to label charges.Results and Discussion
Deduction for Cyclization Reaction of Singly
Charged b-Type Ions
Finding of the unique fragmentation. Initially, we were
interested in sequencing cyclic peptides with antitu-
mor activities and in studying the fragmentation
mechanisms using multistep CAD in an ion trap [26].
Sequencing cyclic peptides usually depends on detec-
tion of b ions [10]. However, some CAD spectra of b
ions present the rearranged fragment ions with losses
of internal amino acid residues [10, 26, 27]. In this
work, we further study the b ions arising from the
linear precursors of these cyclic peptides to verify
whether it is a common phenomenon. In the first step,
the ESI-produced [M  H] of the linear peptides
were subjected to the first stage of CAD to produce
MS2 spectra. No anomalous ions were observed ob-
viously (Figure S1 in Supplementary Material which
can be found in the electronic version of this article).
In the second step, the b ions were selected from the
obtained MS2 spectra and subjected to the second
stage of CAD to produce MS3 spectra. The obtained
data indicate that almost all of the investigated b ions
exhibit the unique fragmentation pattern with inter-
nal residue losses (see the second column in Table 1).
Figure 1a, b, and c illustrate the CAD spectra (MS3 )of
the b6, b5, and b4 ions from peptide PLIFSPI (a
precursor of Stylopeptide 1 [34], respectively. Figure
2a, b, and c give the CAD spectra (MS3 ) of the b6, b5
and b4 ions from peptide PFNSLAI (a precursor of
Stylostatin 1 [35], respectively.
Deduction for cyclization. The MS3 spectrum of b6
PLIFSP (Figure 1a) is taken as a representative case to
introduce the deduction process. According to conven-
tional fragmentation rules, the b6 ion dissociates mainly
via bn¡bn-1 and bn¡an pathways to form lower b- and
a-type ions [16, 36, 37]. The ions b5, b4, b3, and b2 are
observed clearly in the spectrum. On the basis of
classical sequencing methods [1, 3, 16], the sequences of
these b ions are determined as PLIFS, PLIF, PLI,
and PL, respectively. Accordingly, the linear parent
ion b6 are identified as PLIFSP
. However, some anom-
alous ions formed via other fragmentation pathways
reveal sequential elimination of residues from the inte-
rior of the parent ion b6. For example, b6–S at m/z 568.7
differs from b6 at m/z 655.8 by 87.1 Da, the mass of a Ser
residue. The mass differences among b6–S (m/z 568.7),
b6–FS (m/z 421.7), and b6–IFS (m/z 308.6) are 147.0 and
113.1 Da, which respectively, correspond with the mass
of Phe and Ile residues. Furthermore, the anomalous
ions display the feature of b-type ions because some-
times there are a-type ions formed by a CO loss near
them (the evidence shown at the end of the Exploring
Predictive Rules section). Therefore, the sequences of
b6–S, b6–FS, and b6–IFS are deduced as PPLIF
, PPLI,
and PPL, respectively. The sequence of their linear
abun
nnot b
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. Another set of
ions showing sequential elimination of internal residues
are b6–L, b6–PL, b6–PPL, and b6–SPPL. Their sequences
can be deduced as IFSPP, IFSP, IFS, and IF. The
sequence of their linear parent ion b6 is inferred as
IFSPPL. To sum up, there are three deduced sequences
of the parent ion b6, i.e., PLIFSP
, PPLIFS, and
IFSPPL.
To some extent, the deduction method and the
sequencing result described above are very similar to
those of a cyclic peptide sequencing [9, 10, 26, 27]. If
Figure 1a is a MS2 spectrum of [M  H] of a cyclic
peptide, we may determine the sequence of the cyclic
peptide as cyclo(PLIFSP). But it is indeed the MS3
spectrum of b6 PLIFSP
 from the linear peptide
PLIFSPI. Therefore, it can be assumed that b6 PLIFSP

is cyclized to form a CPI cyclo(PLIFSP  H) and the
CPI reopens at different sites to produce the fragment
ions presented in Figure 1a. In addition, from other MS 3
spectra of b ions in Figures 1 and 2 (and the b ions listed
in Table 1), we also observe large-scale anomalous ions
and draw the same conclusion that these b ions as
Table 1. b-Type ions undergoing cyclization reaction in this inv
Peptide
Parent b ions
undergoing
cyclization reaction CPI for
PLIFSPIb b6 PLIFSP

b5 PLIFS

b4 PLIF

PFNSLAIb b6 PFNSLA

b5 PFNSL

b4 PFNS

b3 PFN

IFSPIPb b6 IFSPIP

b5 IFSPI

b4 IFSP

LPVNPFVb b6 LPVNPF

b5 LPVNP

b4 LPVN

VPVNPFVb b6 VPVNPF

b5 VPVNP

b4 VPVN

FPQPFPFIb b7 FPQPFPF

b6 FPQPFP

b5 FPQPF

b4 FPQP

b3 FPQ

APFNSL b5 APFNS

b4 APFN

LPPFI b4 LPPF

b3 LPP

FSPLII b5 FSPLI

b4 FSPL

FPLII b4 FPLI

PVNPF b4 PVNP

aWhen the CPI dissociates via more than two ring-opening pathways,
bLinear precursors of the cyclic peptides showing potential to be antic
cIn the CAD spectra (MS3) of the b3 ions, the anomalous ions are lowly
possibly incomplete. So the preferential ring-opening amide bonds caparent ions have undergone cyclization reactions.Proposed Mechanism for Cyclization Reaction
of b-Type Ions
The MS3 experiment of b4 (PLIF
, m/z 471.6) from
peptide PLIFSPI (Figure 1c) is taken as a representative
case to discuss the unique fragmentation mechanism. In
the MS3 spectrum, not only the normal ions b3 (m/z
324.4) and b2 (m/z 211.3) exhibiting a sequential loss of
residues from C-terminus are observed, but also the
anomalous ions b4–L (m/z 358.5) and b4–PL (m/z 261.4)
displaying a sequential loss of residues from interior are
detected.
MH¡CPI¡bn
rea pathway. A proposed mechanism is
shown in Scheme 2. At the first stage of CAD, the
normal ion b4 can be formed via the conventional bx–yz
pathway [13, 16]. The protonation of the nitrogen of the
amide bond Phe–Ser lowers the bond stability as well as
induces the neighboring carbonyl oxygen to attack the
carbon of the amide bond, leading to cleavage of the
amide bond to form b4 as an oxazolone derivative and
a neutral counterpart (Pathway I) [16, 38]. The b4 ion
ation
by cyclization reaction
Preferential ring-opening
amide bond of CPIa
(PLIFSP  H) Ser-Pro Pro-Pro
(PLIFS  H) Ser-Pro Leu-Ile
(PLIF  H) Phe-Pro Leu-Ile
(PFNSLA  H) Asn-Ser Ala-Pro
(PFNSL  H) Asn-Ser Leu-Pro
(PFNS  H) Asn-Ser Ser-Pro
(PFN  H) —c —c
(IFSPIP  H) Ser-Pro Ile-Pro
(IFSPI  H) Ser-Pro Ile-Ile
(IFSP  H) Ser-Pro Pro-Ile
(LPVNPF  H) Asn-Pro Leu-Pro
(LPVNP  H) Asn-Pro Leu-Pro
(LPVN  H) Asn-Leu Val-Asn
(VPVNPF  H) Asn-Pro Val-Asn
(VPVNP  H) Asn-Pro Val-Asn
(VPVN  H) Asn-Val Val-Asn
(FPQPFPF  H) Gln-Pro Phe-Pro
(FPQPFP  H) Gln-Pro Phe-Pro
(FPQPF  H) Gln-Pro Phe-Phe
(FPQP  H) Gln-Pro Phe-Pro
(FPQ  H) —c —c
(APFNS  H) Ala-Pro Pro-Phe
(APFN  H) Ala-Pro Asn-Ala
(LPPF  H) Leu-Pro Pro-Pro
(LPP  H) —c —c
(FSPLI  H) Ser-Pro Leu-Ile
(FSPL  H) Ser-Pro Phe-Ser
(FPLI  H) Phe-Pro Leu-Ile
(PVNP  H) Pro-Pro Asn-Pro
ain two are listed.
 drugs [34, 35, 43].
dant. Due to containing three residues, the cyclization of the b3 ions is
e determined.estig
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stage of CAD, if the N-terminal nitrogen attacks the
carbon of the amide bond Phe–Ser, a b4 CPI will be
produced by a head-to-tail cyclization reaction (Path-
way III). The fragmentation of the CPI is identical to
that of a protonated cyclic peptide, involving proton
retransfer, ring opening, and subsequent bn¡bn-1 frag-
mentation [16, 26, 39]. At the second stage of CAD, if the
mobile proton locates on the nitrogen of the amide bond
Leu-Ile of the CPI, the neighboring carbonyl oxygen
will attack the carbon of the amide bond, leading to ring
reopening to form the rearranged b4 with the Leu
residue relocated at the C-terminus (Pathway IV). Sub-
sequently, the anomalous ions b4–L and b4–PL are
generated via conventional bn¡bn-1 pathways (Path-
ways V and VI). The series of fragmentations leading to
anomalous ions with internal residue losses is tenta-
tively named as MH¡CPI¡bn
rea pathway.
bn¡CPI¡bn
rea pathway. The b4 CPI can also be formed
via other pathways. The linear b4 ion may be cyclized
by attack of the N-terminal nitrogen on the carbonyl
carbon of oxazolone ring to form the CPI (Pathway VII
in Scheme 2) [25]. The CPI further dissociates to pro-
duce the anomalous b ions (Pathways IV, V, and VI).
The series of unique fragmentations is tentatively
named as bn¡CPI¡bn
rea pathway.
The question that remains is the origination of the
normal b ions, i.e., b3 (m/z 324.4) and b2 (m/z 211.3) in
Figure 1c. Are they really formed via bx–yz (Pathway I)
and subsequent bn¡bn-1 pathways (Pathway II)? The
answer is that other pathways are possible. As stated
above, the CPI reopens at an amide bond whose nitro-
gen is protonated. At the second stage of CAD, if the
CPI reopens at the amide bond Phe–Pro, b4 will be
reproduced via a CPI¡bn
rea pathway (Pathway XIII)
and be further fragmented to produce b3 and b2 (Path-
way II). In some sense, the ions b3 and b2 in Figure 1c
may also be reassigned as b4–F and b4–IF, respectively.
Thus, the real origination of these normal b ions needs
to be determined (see the Fragmentation of Cyclic
Peptide section).
It is worth noting that the MH¡CPI pathway pro-
posed in this investigation has relationship with the
diketopiperazine–yN-n pathway which has been studied
by some groups [13, 16, 40, 41]. These two pathways
(Scheme 3) have the same nucleophile-electrophile mech-
anism and product structures. When the proton is at-
tached to the produced cyclic peptide to form a CPI ion, it
is a MH¡CPI pathway. On the other hand, when the
proton is attached to the produced C-terminal fragment to
form a y-type ion, it is a diketopiperazine–yN-n pathway.
The alternation of these two fragmentation pathways is
induced by a proton transfer between these two product
fragments: cyclic peptide and C-terminal fragment. Possi-
bly, these two pathways occur together and transform
each other.
The cyclization phenomenon of doubly charged b
ions has been found by Yagüe et al. [22] and a similarmechanism has been proposed for the formation of
cyclic b ions and amino acid rearrangement. Following
their research, we try to introduce the fragmentation
mechanism of cyclic peptides into CPIs and to find
some fragmentation rules. Moreover, it should be noted
here that Harrison, Paizs et al. [25] published a commu-
nication about cyclization of singly charged b ions.
Their experimental and computational results provide
great insight into our proposed mechanism.
To support our proposed mechanisms, four points
should be verified by experiments. (1) The assumption
that the cyclization reaction requires a free N-terminus
will be examined by peptide N-acetylation; (2) the
existence of cyclization reaction and CPI will be verified
by MS4 and rearranged-ion design; (3) the hypothesis
that CPIs have the same fragmentation pattern as
protonated cyclic peptides will be tested by fragmenta-
tion of synthetic cyclic peptides; (4) the factors affecting
the cyclization reaction and the CPI fragmentation will
be determined by performing activation-time adjust-
ment and peptide modification as well as by generaliz-
ing the fragmentation rules of a number of b ions.
Evidence to Support the Proposed Mechanism
for b-Type Ions
Peptide N-acetylation. To examine whether the cycliza-
tion requires a free N-terminus, N-acetylation experi-
ments were performed. Peptides were acetylated in solu-
tion and directly subjected to ESI, but the sample cannot
be ionized effectively. To obtain efficient ionization, pep-
tide IFSPIPL (another precursor of Stylopeptide 1 [34] was
acetylated on resin and then cleaved from resin to yield
pure N-acetylated peptide. Because the Ser side chains
were still protected by t-butyl groups during acetylation,
there was no acetylation to the Ser residues.
Figure 3a and b illustrate a comparison of MS3
spectra between b5 (IFSPI
, m/z 558.7) from peptide
IFSPIPL and b5
E (CH3CO-IFSPI
, m/z 600.7) from N-
acetylated peptide CH3CO-IFSPIPL. The anomalous
ions are presented in the MS3 spectrum of b5
(Figure 3a). In contrast, when the N-terminus is blocked
by an acetyl (42 Da), these anomalous ions are absent
in the MS3 spectrum of b5
E (Figure 3b). The same
phenomenon can also be found by comparing the MS3
spectra of b4 (IFSP
,m/z 445.5) with that of b4
E (CH3CO-
IFSP, m/z 487.5) ions (Figure 3c, d). These experimental
results indicate that the N-acetylation hinder the N-
terminal nitrogen from attacking the carbonyl carbon of
the C-terminus or one amide bond. Thus, the
MH¡CPI¡bn
rea or bn¡CPI¡bn
rea pathway no longer
takes place, leading to disappearance of anomalous
ions.
In addition, in the MS2 spectrum of peptide IFSPIPL,
the y and b ions are observed with relatively higher
intensities (Figure S2A), whereas in that of N-acetylated
peptide CH3CO-IFSPIPL, the y and b
E ions is detected
with relatively lower intensities (Figure S2B). The pos-
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Figure 1. CAD spectra (MS3) of the (a) b6, (b) b5, and (c) b4 ions from peptide PLIFSPI. In this and
the following figures, all of the anomalous ions with internal residue losses are labeled in bold font;
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Figure 2. CAD spectra (MS3) of the (a) b6, (b) b5, and (c) b4 ions from peptide PFNSLAI.
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bx–yz, diketopiperazine–yN-n and MH
¡CPI pathways
are available for producing the y and b ions. However,
as the N-terminus is acetylated, the fragmentations via
MH¡CPI and diketopiperazine–yN-n pathways are
ceased, resulting in the decrease of the produced y and
HN
CH
C
C
H2
O
CH
H3C
H3C
H2N
+
CH
CH
CH3
H2C
H3C
CH NHC
O
N
H
CH
C
CH2
O
CH
H3C
H3C
HN
CH
CCH
OCH3
C
H2
H3C
H
N CH C
CH2 O
+H2
N CH C
CH2 O
OH
C-terminus
Pro
Leu
Ile
Phe Ser
Il
Leu
CH
N
C
O
NHCH
C
CH2
O
CH
H3C
H3C
H2N
CH
C
CH
O
CH3
H2C
H3C
NH
CH
C
CH2
O
Pro
Phe
Ile
Leu
NHCH
C
CH2
O
CH
H3C
H3C
H
H3C
Leu
Pro Ile
[M+H]+ of peptide
[PLIFSPI+H]+
m/z 787.0
rearranged b4
IFPL+
m/z 471.6
H2N CH C
CH2 O
OH
C-terminus
Ser Pro Ile
III
IV
V
III
IV
I
ScbE ions.MS4 experiment. MS4 experiments were carried out to
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stage of CAD to produce MS4 spectra, respectively. In
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Moreover, the spectra illustrate that b5–S and b5–F,
which have lost internal residues from the parent ion b5,
undergo cyclization again to produce anomalous ions
with internal residue losses. Further, the MS4 experi-
ment was performed on b5
0 at m/z 540.7 (Figure 3a).
From the obtained MS4 spectrum (Figure S3C), frag-
ment ions with losses of internal residues and one
molecular water, e.g., b5
0–F (m/z 393.5, 22%) and b5
0–IF
(m/z 280.6, 38%) are seen, revealing that the parent ion
b5
0 has undergone cyclization reaction. This also indi-
cates that in Figure 3a the anomalous ions with loss of
one water molecule, such as b5
0–F and b5
0–IF, derive
from fragmentation of b5
0 CPI.
Rearranged-ion design. If the cyclization reaction and
the CPI exist during fragmentation, two b ions with
different amino acid sequences, which can be cyclized
to form the same CPI, may produce identical fragments
and CAD spectra. For instance, PLIFS and FSPLI can
both be cyclized to generate CPI cyclo(FSPLI  H),
and the CPI is able to further dissociate to produce the
identical CAD spectra. Thus, peptides FSPLII and FPLII
were designed and synthesized. Figure 4a shows the
MS3 spectrum of b5 (FSPLI
, m/z 558.7) from peptide
FSPLII, which is designed for comparison with that of
the b5 (PLIFS
, m/z 558.7) from peptide PLIFSPI shown
in Figure 1b. Surprisingly, the two spectra have the
identical fragment ions and even the corresponding
relative intensities. Similarly, the MS3 spectrum of b4
(FPLI, m/z 471.6) from peptide FPLII (Figure 4b) is
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Scheme 3identical to that of b4 (PLIF
, m/z 471.6) from peptidePLIFSPI (Figure 1c). These experimental results are
consistent with our hypothesis. Interestingly, the MS3
spectrum of IFSPI (Figure 3a) is almost identical to
those of PLIFS (Figure 1b) and FSPLI (Figure 4a). The
reason is that IFSPI can be cyclized to form
cyclo(IFSPIH) and PLIFS/FSPLI can be similarly
cyclized to form cyclo(IFSPLH). Note that the fifth
residue of the former CPI is Ile, and that of the latter is
Leu. The two CPIs are able to dissociate via similar
fragmentation pathways to produce the identical CAD
spectra because the isomeric residues Ile and Leu have
similar features. The evidences described above
strongly prove our assumption about cyclization
reaction.
Activation-time adjustment. It has been reported that
the similar cyclization reactions of other fragment ions
rely on time scales of collisional activation [19, 20, 22].
For experiments performed at the first stage of CAD
(MS2), it was easy to adjust the activation time. How-
ever, our experiments were carried out using two stages
of CAD (MS3), so the cyclization reaction of b ions may
occur at each stage of CAD, leading to two stages of
activation times requiring adjustment. As activation
time was reduced, relative intensities of some anoma-
lous ions decreased. However, when the activation time
at each stage was less than 3 ms, many desired ions
could not be detected due to low signals. Thus, it was
difficult to measure the critical value of activation time
required for cyclization. On the contrary, we used long
activation times (30 to 8000 ms) to study the effect of
activation time on the fragment-ion intensity relation-
ship of b5 from PLIFSPI. No fundamental change was
found in comparison between the spectra obtained
using activation times of 30 (Figure 1b) and 8000 ms
(Figure S4). Figure S5 shows the ratios of the fragment-ion
intensities versus the activation time, which reflects the
competitive relationship between the normal bn¡bn-1
pathway and the anomalous CPI¡bn
rea¡bn-1
rea pathway.
b5–L&I and b5–F arise from fragmentation of CPI via
MH¡CPI¡b5
rea¡b4
rea and b5¡CPI¡b5
rea¡b4
rea; b4
derives from fragmentation of the linear b5 ion via b5¡b4
and from fragmentation of the cyclic b5 CPI ion via
CPI¡b5¡b4. As the activation time rises, the (b5–L&I)/b4
and (b5–F)/b4 ratios both increase, indicating that the long
time activation inside an ion trap benefits the occurrence
of cyclization reaction. However, the increments of the
ratios are not large, revealing that the cyclization reaction
and the CPI fragmentation can be mainly accomplished in
a normal activation time of 30 ms at each stage of CAD.
Fragmentation of synthetic cyclic peptide. To explore
whether the CPI produced by b ion cyclization has the
same fragmentation pattern as protonated cyclic pep-
tide produced by ESI, the cyclic peptide cyclo(PFNSLA)
was synthesized and analyzed by ESI-MS/MS to pro-
duce a MS2 spectrum (Figure S6), which was used for
comparison with the MS3 spectrum of b6 PFNSLA
from peptide PFNSLA (Figure 2a). (Cyclo[PFNSLA] has
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Figure 4. CAD spectra (MS3) of (a) the b ion from peptide FSPLII, (b) the b ion from peptide FPLII,5 4
and (c) the b5 ion from peptide APFNSL.
674 JIA ET AL. J Am Soc Mass Spectrom 2007, 18, 663–678been sequenced by multistep MS/MS in our previous
work [26].) As we expected, these two spectra have the
same fragment ions and relative intensities, strongly
demonstrating that CPIs have the same dissociation
feature as protonated cyclic peptides. This experimental
result also clarifies the fact that the normal b ions, such
as b3 (m/z 359.4) and b2 (m/z 245.3) in Figure 2a, mostly
originate from CPI fragmentation. Moreover, Harrison
et al. [25] reported that the b5 ion from peptide LFGAY
gave a breakdown graph, which was very similar to
that of protonated cyclo(LFGAY). This finding also
confirms the assumption proposed above.
Exploring Predictive Rules for the Unique
Fragmentation of b-Type Ions
Because the MH¡CPI¡bn
rea or bn¡CPI¡bn
rea path-
way includes the processes of cyclization and ring
opening, the predictive rules involve two aspects, i.e.,
predictability of cyclization reaction and predictability
of CPI ring opening.
Predictive rules for cyclization reaction. All of the six
parent b ions in Figures 1 and 2, which have undergone
cyclization reaction, have Pro residues located at N-
termini. The Pro residue with a high proton affinity [28]
is easy to initiate a nucleophilic attack on the C-
terminus or one amide bond. Do the N-terminal Pro
residues contribute to the high-frequency of cyclization
reactions? To answer this question, we performed pep-
tide modification. The b ion APFNS was designed to
compare its CAD spectrum with that of PFNS in
Figure 2c. An Ala residue is added to the N-terminus of
PFNS to block the Pro residue without breaking the
C-terminal conformation in gas phase. In Figure 4c
many anomalous ions are presented, demonstrating
that APFNS have also suffered from cyclization. This
means that the N-terminal Pro has no obvious relation-
ship with the occurrence of cyclization reactions.
Other investigations [19, 22] have demonstrated that
displacing internal residues cannot prevent a- and
b2-type ions from cyclizing. Nevertheless, for cyclic
peptide synthesis in solution or solid phase, the yield of
cyclization strongly relies on choice of cyclization sites,
i.e., the two terminal residues of linear peptides [42].
This means that the two terminal residues possibly
affect b ion cyclizations. Moreover, in Figure 1a, b, and
c, b6 (PLIFSP
), b5 (PLIFS
), and b4 (PLIF
) as parent
ions all undergo cyclization reactions, revealing that the
change of the C-terminal residues cannot influence
cyclization reactions. Also, the cyclizations of the b ions
from peptides PFNSLAI (Figure 2) and IFSPIPL
(Figure 3) all support this point. As a result, the most
possible factor to affect cyclization reactions is the
characteristics of N-terminal residues. To examine
whether N-terminal residues control the cyclization
process in gas phase, two peptides LPVNPFV and
VPVNPFV (precursors of Axinastatin 3 and 1 [43] weresynthesized. Figure 5a and b show the MS3 spectra of b6
(LPVNPF, m/z 668.8) from peptide LPVNPFV and b6
(VPVNPF, m/z 654.8) from peptide VPVNPFV, respec-
tively. Apparently, the two b ions have undergone
cyclization reactions. Furthermore, the two b6 ions
display similar fragmentation patterns. For instance,
b6–PV at m/z 472.6 in panel A corresponds with b6–PV
at m/z 458.5 in panel B; b6–VN at m/z 455.6 in panel A
corresponds with b6–VN at m/z 441.6 in panel B. Simi-
larly, the phenomenon has also been found in the MS3
spectra of the b5 ions from these two peptides (Figure
5c, d). Overall, no evidence reveals that the cyclization
reaction is predictable. In other words, the unique
fragmentation reaction is very intensive.
Predictive rules for CPI ring opening. To some extent, the
CPI ring opening may be predicted. As discussed
above, the CPIs and the protonated cyclic peptides have
the same fragmentation pattern. It has been reported
that fragmentations of protonated cyclic peptides con-
taining Pro, Asn, Gln, Asn, and Glu always display
selective ring-opening behaviors [10, 26, 44, 45]. For
example, the amide bonds Xxx-Pro [28] and Asn/Gln-
Xxx [16, 29] show enhanced cleavage. Similarly, the
fragmentations of CPIs also display the selective ring-
opening behaviors. Table 1 lists all of the investigated b
ions, the formed CPIs and the preferred ring-opening
amide bonds, which clearly exhibits the “Pro and Asn/
Gln effects” acting on CPIs. As a result, if we consider
CPIs as protonated cyclic peptides, many of the frag-
mentations will be predictable.
Finally, two questions remain to be addressed. First,
the b6–S  H2O ion at m/z 586.6 and the b6–FS  H2O
ion at m/z 439.7 are presented in Figure 1a. Since the
parent b6 ion PLIFSP
 contain a Ser residue, this type of
ions belongs to bn-1  H2O [46, 47] or bn-1  H  OH
[48] ions. These ions can also be found in other CAD
spectra of serine-containing ions. Second, in Figure 5a it
is observed that b6–N at m/z 554.7 is accompanied by
a6–N atm/z 526.7. This phenomenon that b-type ions are
accompanied by a-type ions can also be observed from
other spectra (Figure 5b, c, d). This proves that the
anomalous ions have the features of b-type ions as
assumed above.
Cyclization Reaction of Singly Charged
a-Type Ions
Vachet et al. [19] described that the cyclization reaction
of the singly charged a-type ion accompanied by an
NH3 loss can induce an internal residue loss from the
second position of C-terminus. This unique fragmenta-
tion was observed when a mixture of helium and 5%
xenon was used as collision gas in an ion trap. In our
CAD experiments using pure helium as collision gas,
the same phenomenon has also been found. In addition,
we noted that the internal residues can be eliminated
from different positions.
PVN
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SPI–CO from peptide IFSPIPL (Figure 6), the anoma-
lous ions a5*P at m/z 416.5 and a5*SP at m/z 329.5 are
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m peand a5*–IF at m/z 253.5 are presented in Figure 6; a5*–IF
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(Figure S7B). The results demonstrate that the Phe
residue is lost from the fourth position of the C-
terminus of IFSPI–CO. When peptide IFSPIPL is N-
acetylated, the anomalous fragmentation no longer oc-
curs (Figure S8), indicating that the cyclization also
needs a free N-terminus. Table 2 lists the parent a-type
ions and the observed anomalous ions in this study.
Interestingly, the acquired spectra are always domi-
nated by an*–P ions, indicating that Pro residues are
preferred to lose from interior of parent ion. In other
words, the amide bond Pro-Xxx in CPIs formed by
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Figure 6. CAD spectrum (MS3) of the a5 ion from peptide
IFSPIPL.
Table 2. a-Type ions undergoing cyclization reaction in this inv
Peptide
Parent a-type ions
undergoing
cyclization reactiona
Anomalous frag
IFSPIPL a5 IFSPI
–CO a5*–P (m/z 416.5, 7
a5*–F (m/z 366.6, 3
LPVNPFV a6 LPVNPF
–CO a6*–P (m/z 526.8, 1
a5 LPVNP
–CO a5*–P (m/z 379.3, 1
a4 LPVN
–CO a4*–P (m/z 282.2, 1
VPVNPFV a6 VPVNPF
–CO a6*–P (m/z 512.6, 1
a6*–VNP (m/z 299.
a5 VPVNP
–CO a5*–P (m/z 365.5, 6
a4 VPVN
–CO a4*–P (m/z 268.3, 7
FPQPFPFI a7 FPQPFPF
–CO a7*–P (m/z 719.9, 1
a7*–PFP (m/z 475.8
a5 FPQPF
–CO a5*–P (m/z 475.7, 1
PFNSLAI a6 PFNSLA
–CO a6*–P (m/z 488.6, 4
a6*–S (m/z 498.6, 1
a5 PFNSL
–CO a5*–P (m/z 417.5, 1
a5*–NS (m/z 313.5
PLIFSPI a5 PLIFS
–CO a5*–P (m/z 416.8, 1
a5*–PL (m/z 303.6,
a4 PLIF
–CO a4*–P (m/z 346.5, 1
FSPLII a5 FSPLI
–CO a5*–P (m/z 416.6, 8
a5*–F (m/z 366.6, 2
a4 FSPL
–CO a4*–P (m/z 303.3, 1
LPPFI a4 LPPF
–CO a4*–P (m/z 313.4, 1
aThe internal residues which are preferred to lose are labeled in bold fo
the right position of Asn is easy to lose.
bWhen the CPI dissociates via more than one ring-opening pathway, the pre
cThe preferred ring-opening amide bond cannot be determined.a-type ion cyclization is preferred to cleave, which
contrasts with the conventional concept that Xxx-Pro is
easy to cleave [28].
Proposed mechanism. A proposed mechanism of the
unique fragmentation is shown in Scheme 4. The an ion
can be cyclized to form a CPI accompanied by an NH3
loss (Pathway I) [19, 24]. The CPI reopens to produce
the rearranged an* ion (acylium ion or protonated
oxazolone) where the second residue (the ‘n-1’th resi-
due) of the C-terminus of the parent ion relocate at the
C-terminus of the new ion (Pathways II and III). The
rearranged an* ion with the feature of b-type ions
further dissociates via bn¡bn-1 pathways to generate
the anomalous ion with loss of the second residue (the
‘n-1’th residue) of C-terminus (Pathway IV). In our
experiment, the anomalous ions with losses of residues
at other positions have been found as depicted above,
indicating that the CPI is able to reopen at other amide
bonds (Pathway I in Scheme 5). The ‘k’th residue can be
removed by further dissociation of the rearranged an
A
ion (Pathway III).
It should be noted that the ring opening of a proton-
ated cyclic peptide is initiated by a proton transfer,
whereas the a-type ion CPI is a fixed-charge structure
without any mobile protons. Therefore, the “Pro effect”
cannot influence CPI ring openings, causing Xxx-Pro no
longer to be the preferred cleavage site. Why do amide
bonds Pro-Xxx in the CPIs exhibit enhanced cleavage?
ation
t ions with internal amino-acid
idue losses
Preferred ring-opening
amide bond of CPIb
a5*–SP (m/z 329.5, 45%) Pro-Ile
a5*–IF (m/z 253.5, 1%)
) a6*–NP (m/z 412.7, 12%) Pro-Phe
) —c
a4*–LP (m/z 169.4, 2%) Pro-Val
) a6*–NP (m/z 398.7, 22%) Pro-Phe
)
—c
a4*–VP (m/z 169.4, 5%) Pro-Val
) a7*–FP (m/z 572.9, 44%) Pro-Phe
)
) a5*–FP (m/z 328.5, 42%) Pro-Gln
a6*–L (m/z 472.6, 19%) Pro-Phe
a6*–NS (m/z 384.7, 14%)
a5*–S (m/z 427.6, 9%) Pro-Phe
a5*–L (m/z 400.6, 2%) Pro-Leu
a4*–L/I (m/z 313.4, 11%) —
c
a5*–SP (m/z 329.5, 5%) Pro-Leu
) Pro-Leu
) Pro-Pro/Phe
he two residues Asn-Xxx are underlined, indicating that the residue atestig
men
res
4%)
%)
00%
00%
2%)
00%
6, 4%
4%)
%)
00%
, 59%
00%
4%)
7%)
5%)
, 9%)
1%)
5%)
%)
%)
%)
00%
00%
nt. Tferred one is listed.
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opening pathway of the CPI is reversible (Pathways I
and II in Scheme 5). In the process of fragmentation, if
the rearranged an* ion never dissociate timely to pro-
duce anomalous ions with internal residue losses (Path-
way III), the reversible reaction will occur to reform the
CPI (Pathway II). The an* acylium ion can transform to
the protonated oxazolone ion. The latter structure has a
mobile proton, so it can be affected by the “Pro effect”.
Therefore, if a Pro residue is relocated at the C-terminus
of the rearranged an* ion, the amide bond Xxx-Pro will
be preferred to cleave via the bn¡bn-1 pathway to form
an an*P ion (Pathway III), driving the reversible
reaction toward right orientation (Pathway I). On the
basis of the “pathways in competition” model [16], the
ring-opening pathways of the CPI are competitive. As a
result, the amide bond Pro-Xxx in CPI is preferred to
dissociate. In a word, the “Pro effect” cannot act on ring
opening of CPI, but can act on dissociation of the
rearranged an* ion formed by ring opening of CPI.
Consequently, it can be concluded that the enhanced
cleavage of an* ion at Xxx-Pro results in the preferred
ring opening of CPI at Pro-Xxx. Additionally, another
interesting finding can further support this explanation.
From Table 2 it is found that the residue at the right
position of Asn is easy to lose, revealing that the right
amide bond of Asn-Xxx-Xxx in CPI is preferential to
cleave. The phenomenon also indicates that the “Asn
effect” cannot act on ring opening of CPI, but can act on
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Scheme 4dissociation of the rearranged an* ion.Conclusions
In this investigation, it was found that internal amino
acid residues could be lost from singly charged b- and
a-type ions during multistage CAD. Our results indi-
cate that the unique fragmentations are induced by
cyclization reactions.
b-Type Ions
The cyclization of b ion is initiated by a nucleophilic
attack of the N-terminal nitrogen on the carbonyl car-
bon at C-terminus or at one amide bond to produce a
CPI. Subsequently, the CPI is reopened at another
position and an internal residue is relocated at the
C-terminus. The ring-opened structure further dissoci-
ates via bn¡bn-1 pathways to produce the anomalous
ions with internal residue losses. This reaction can be
mainly completed in activation time of 30 ms. The CPI
produced by b ion cyclization displays the same frag-
mentation pattern as the protonated cyclic peptide
produced by ESI, and shows selective ring-opening
behaviors owing to the “Pro and Asn/Gln effects”.
a-Type Ions
The a-type ion can be cyclized to form a CPI accompa-
nied by an NH3 loss. The CPI may then reopen at
different positions to generate rearranged an* ions with
the feature of b-type ions. The rearranged an* ions
further dissociate via bn¡bn-1 pathways to form anom-
alous ions with internal residue losses. The CPI is a
fixed-charge structure, whereas the rearranged an* ion
has a mobile proton. Therefore, the “Pro and Asn
effects” cannot act on the former but can act on the
latter.
Overall, we studied a limited number of synthetic
peptides, so we cannot yet conclude that the cycliza-
tions of b- and a-type ions are very general phenomena
for other peptides, such as tryptic and natural peptides.
If the phenomena receive further attention, the new
cyclization reactions of other ions will possibly be
discovered and the misidentification of fragments and
sequences of peptides will be avoided.
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